CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,484,458
-$471,742 QoQ
Shares Held
518,342
+11.1% QoQ
Ownership
0.592%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 182 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. OLMA ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in OLMA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,484,458 | 518,342 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,956,200 | 466,546 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,178,525 | 407,141 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,868,293 | 395,127 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,834,023 | 430,522 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,312,326 | 349,023 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,941,098 | 332,950 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,949,286 | 330,761 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,332,980 | 123,196 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $984,353 | 86,957 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,251,616 | 89,210 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $987,407 | 79,952 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $721,966 | 79,952 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $64,472 | 18,580 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $45,521 | 18,580 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $51,280 | 18,580 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $558,672 | 137,266 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $815,922 | 191,531 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,896,429 | 202,610 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,402,421 | 196,024 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,278,523 | 81,434 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,608,478 | 78,616 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||